CALI bridges your Physiology to your Psychology
The Cognipatch was built on peer-reviewed literature from UC Berkeley, Harvard, MIT, UCSF, and Stanford Medical School.
CALI's Supporting Literature
Our Scientific Rationale
Aggregate evidence from the research literature supporting the physiological biomarker approach to anxiety and depression monitoring.
- Anxiety disorders are associated with lower resting heart rate variability across 36 studies covering more than 4,300 people. (Chalmers et al. 2014, Frontiers in Psychiatry)
- Heart rate variability is also altered in major depression, shown in a 21-study meta-analysis (2,250 patients, 1,982 controls) restricted to unmedicated adults. (Koch et al. 2019, Psychological Medicine)
- Muscle activity (EMG) was the second most sensitive of the physiological measures tested (d = 0.71) for anxiety in children and adolescents, in a 25-study meta-analysis of 2,502 participants. Skin conductance level ranked first (d = 0.83). (Ko et al. 2024, Stress and Health)
- In a 359-person study, more depression and anxiety symptoms and diagnoses were associated with larger disturbances in sleep, circadian rhythm, and physical activity measured by a wrist-worn accelerometer. (Difrancesco et al. 2019, Depression and Anxiety)
- Personalized deep learning models predicted most of the variation in anxiety symptoms (R² = 0.748) in a 32-person study using smartphone sensors. (Jacobson & Bhattacharya 2022, Behaviour Research and Therapy)
- Wearable movement and sleep data predicted anxiety symptom deterioration over 17–18 years in 265 adults. (Jacobson et al. 2021, Journal of Affective Disorders)
Join CALI's Community
We are actively seeking psychiatric research institutions, academic medical centers, and clinical investigators interested in physiological monitoring for anxiety and depression. Collaborations for protocol development and multi-site study participation welcome.
Get In TouchMulti-site clinical study currently in planning phase. IRB protocol under preparation. Target participant population: adults with a confirmed DSM-5 anxiety disorder or major depressive disorder diagnosis, currently under psychiatric care.

